Stereotaxis Stock Today

STXS -  USA Stock  

USD 1.99  0.11  5.24%

Market Performance
0 of 100
Odds Of Distress
Over 97
Stereotaxis is selling at 1.99 as of the 24th of June 2022; that is -5.24 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.93. Stereotaxis has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Stereotaxis are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of December 2021 and ending today, the 24th of June 2022. Click here to learn more.
CUSIP
85916J102
Fiscal Year End
December
Business Domain
Health Care Equipment & Services
IPO Date
12th of August 2004
Category
Healthcare
Classification
Health Care
ISIN
US85916J4094
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri. The company has 74.58 M outstanding shares of which 1.71 M shares are at this time shorted by private and institutional investors with about 5.74 trading days to cover. More on Stereotaxis

Moving together with Stereotaxis

0.78FMBLFarmers Merch Bk Earnings Call  In Two WeeksPairCorr

Moving against Stereotaxis

0.75VTNRVertex Energy Normal TradingPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Stereotaxis Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Stereotaxis' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Stereotaxis or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Stereotaxis generated a negative expected return over the last 90 days
Stereotaxis may become a speculative penny stock
Stereotaxis has high historical volatility and very poor performance
Stereotaxis has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 35.02 M. Net Loss for the year was (12.06 M) with profit before overhead, payroll, taxes, and interest of 23.23 M.
Stereotaxis currently holds about 38.74 M in cash with (2.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52.
Roughly 57.0% of the company shares are owned by institutional investors
Latest headline from www.benzinga.com: Global Electrophysiology Market Report - Featuring Abbott Laboratories, Boston Scientific - Benzinga
Chairman of the Board, CEOWilliam Mills
Average Analyst Recommendation
Analysts covering Stereotaxis report their recommendations after researching Stereotaxis' financial statements, talking to executives and customers, or listening in on Stereotaxis' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Stereotaxis. The Stereotaxis consensus assessment is calculated by taking the average forecast from all of the analysts covering Stereotaxis.
Strong Buy4 Opinions
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Stereotaxis based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Stereotaxis financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 5 - HealthyDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares70.6 M65.5 M
Significantly Up
Increasing
Slightly volatile
Weighted Average Shares Diluted70.6 M65.5 M
Significantly Up
Increasing
Slightly volatile
Total Assets52.6 M63.8 M
Significantly Down
Increasing
Stable
Total Liabilities18 M17.5 M
Fairly Up
Decreasing
Slightly volatile
Current Assets49.1 M60.6 M
Significantly Down
Increasing
Stable
Current Liabilities22.9 M15.6 M
Way Up
Decreasing
Slightly volatile
Total Debt15.8 M16.3 M
Sufficiently Down
Decreasing
Stable
Return on Average Assets(13.03)(12.08)
Significantly Down
Increasing
Slightly volatile
Gross Margin64.4464.1
Slightly Up
Decreasing
Stable
Asset Turnover0.490.48
Fairly Up
Decreasing
Stable
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Stereotaxis' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong BuyUndervalued
Financial Strength
Stereotaxis' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Stereotaxis' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Stereotaxis' financial leverage. It provides some insight into what part of Stereotaxis' total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Stereotaxis' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Stereotaxis deploys its capital and how much of that capital is borrowed.
Liquidity
Stereotaxis cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 6.11 M in liabilities with Debt to Equity (D/E) ratio of 0.16, which may suggest the company is not taking enough advantage from borrowing. Stereotaxis has a current ratio of 3.8, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Stereotaxis until it has trouble settling it off, either with new capital or with free cash flow. So, Stereotaxis' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Stereotaxis sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Stereotaxis to invest in growth at high rates of return. When we think about Stereotaxis' use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(3.41 Million)Share
Stereotaxis (STXS) is traded on AMEX Exchange in USA and employs 130 people. The company currently falls under 'Small-Cap' category with current market capitalization of 135.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Stereotaxis's market, we take the total number of its shares issued and multiply it by Stereotaxis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Stereotaxis conducts business under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 74.58 M outstanding shares of which 1.71 M shares are at this time shorted by private and institutional investors with about 5.74 trading days to cover. Stereotaxis currently holds about 38.74 M in cash with (2.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52.
Check Stereotaxis Probability Of Bankruptcy
Ownership
Stereotaxis maintains a total of 74.58 Million outstanding shares. Over half of Stereotaxis outstanding shares are owned by institutional holders. These institutional holders are typically referred to corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulation than regular investors in Stereotaxis. Please watch out for any change in the institutional holdings of Stereotaxis as this could mean something significant has changed or about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Stereotaxis Ownership Details

Stereotaxis Stock Price Odds Analysis

What are Stereotaxis' target price odds to finish over the current price? In regard to a normal probability distribution, the odds of Stereotaxis jumping above the current price in 90 days from now is about 78.74%. The Stereotaxis probability density function shows the probability of Stereotaxis stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.9318. This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Stereotaxis will likely underperform. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Stereotaxis is significantly underperforming DOW.
  Odds Below 1.99HorizonTargetOdds Above 1.99
21.21%90 days
 1.99 
78.74%
Based on a normal probability distribution, the odds of Stereotaxis to move above the current price in 90 days from now is about 78.74 (This Stereotaxis probability density function shows the probability of Stereotaxis Stock to fall within a particular range of prices over 90 days) .

Stereotaxis Historical Income Statement

Stereotaxis Income Statement is one of the three primary financial statements used for reporting Stereotaxis's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Stereotaxis revenue and expense. Stereotaxis Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Stereotaxis Weighted Average Shares Diluted is relatively stable at the moment as compared to the past year. Stereotaxis reported last year Weighted Average Shares Diluted of 65.47 Million View More Fundamentals

Stereotaxis Stock Against Markets

Picking the right benchmark for Stereotaxis stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Stereotaxis stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Stereotaxis is critical whether you are bullish or bearish towards Stereotaxis at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Stereotaxis without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Correlation Analysis Now

   

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Module

Stereotaxis Corporate Directors

Stereotaxis corporate directors refer to members of a Stereotaxis board of directors. The board of directors generally takes responsibility for the Stereotaxis' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Stereotaxis' board members must vote for the resolution. The Stereotaxis board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Duane DeSisto - DirectorProfile
Ross Levin - DirectorProfile
Euan Thomson - Independent DirectorProfile
Eric Prystowsky - Independent DirectorProfile

Investing Stereotaxis

You need to understand the risk of investing before taking a position in Stereotaxis. The danger of trading Stereotaxis is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Stereotaxis is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Stereotaxis. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Stereotaxis is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, take a look at World Market Map. Note that the Stereotaxis information on this page should be used as a complementary analysis to other Stereotaxis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Stereotaxis Stock analysis

When running Stereotaxis price analysis, check to measure Stereotaxis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stereotaxis is operating at the current time. Most of Stereotaxis' value examination focuses on studying past and present price action to predict the probability of Stereotaxis' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Stereotaxis' price. Additionally, you may evaluate how the addition of Stereotaxis to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Stereotaxis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stereotaxis. If investors know Stereotaxis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stereotaxis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
156.8 M
Quarterly Revenue Growth YOY
-0.18
Return On Assets
-0.17
Return On Equity
-0.34
The market value of Stereotaxis is measured differently than its book value, which is the value of Stereotaxis that is recorded on the company's balance sheet. Investors also form their own opinion of Stereotaxis' value that differs from its market value or its book value, called intrinsic value, which is Stereotaxis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stereotaxis' market value can be influenced by many factors that don't directly affect Stereotaxis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stereotaxis' value and its price as these two are different measures arrived at by different means. Investors typically determine Stereotaxis value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stereotaxis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.